Clinical Trial Update: Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer

View source ↗

Summary

A clinical trial update describing a Patient Relevant Outcomes Improvement Program in high-risk HR-positive/HER2-negative early breast cancer, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut fuer Frauengesundheit | Conditions: HR+/HER2- Early Breast Cancer | Status: RECRUITING